U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087054) titled 'Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen' on July 09.
Brief Summary: A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. The purpose of this study is to continue the evaluation of the safety, efficacy, and pharmacokinetics (PK) of paltusotine in participants with carcinoid syndrome.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Carcinoid Syndrome
Carcinoid
Carc...